NL-OMON21894招募中不适用
Revised dosing recommendations of ciprofloxacin for patients with impaired renal function: a bioequivalence study
Amsterdam UMC, location AMC0 个研究点目标入组 46 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •being treated with ciprofloxacin intravenously ( or orally ( as part of standard care
- •- age 18 years
- •- being admitted to general wards of the Ams terdam UMC location AMC or the OLVG location Oost
- •- informed consent is obtained
排除标准
- •- receiving renal replacement therapy i.e. haemodialysis, peritoneal dialysis, continuous venovenous hemofiltration or another way of renal replacement therapy), during the first 48 hours of treatment with ciprofloxacin
- •- patients with cystic fibrosis (CF)
- •- informed consent is not obtained
研究者
相似试验
招募中
4 期
Revised dosing of Ciprofloxacin for patients with impaired renal function: a bioequivalence studybacterial infection2024-520379-28-00Amsterdam UMC Stichting58
招募中
4 期
Revised dosing recommendations of ciprofloxacin for patients with impaired renal function: a bioequivalence study.Bacterial infectionsinflammation1000401810038430NL-OMON52449Academisch Medisch Centrum58
已完成
不适用
To study ciprofloxacin pharmacokinetics in patients who are critically ill and undergoing continuous dialysisPatients on dialysisNutritional, Metabolic, EndocrineRenal failureISRCTN52722850Trinity College Dublin (Ireland)7
已完成
不适用
A study of the concentration of ciprofloxacin in the body over time when given by mouthSevere acute malnutritionNutritional, Metabolic, EndocrineUnspecified protein-energy malnutritionISRCTN31079753Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme (Kenya)52
进行中（未招募）
不适用
Investigation of pharmacokinetics of Ciprofloxacin and Piperacillin/Tazobactam in Patients receiving continuous renal replacement therapyEUCTR2010-021369-66-DEDepartment of Pharmacy Universitaetsmedizin Mainz40